The week at Retraction Watch featured the retraction of a paper linked to vaccines, and what happens when a journal retracts 107 papers at once. Here’s what was happening elsewhere:
A company that indexes journals — thereby assigning them impact factors — has chosen to delist a cancer journal after it retracted 107 papers earlier this year for faked peer reviews. Starting July 19, anything published by Tumor Biology will not be indexed in Web of Science, part of Clarivate Analytics (formerly part of Thomson … Continue reading When a journal retracts 107 papers for fake reviews, it pays a price
The week at Retraction Watch featured a look at publishing bounties around the world, and the story of how the “right to be forgotten” law had led to a retraction. Here’s what was happening elsewhere:
A trove of internal documents from Monsanto, recently unsealed in a lawsuit against the agricultural biotech giant, has revealed the firm’s role in the knotty tale of a paper from the lab of a scientist known for his stance against genetically modified organisms (GMOs). That paper is “Long term toxicity of a Roundup herbicide and … Continue reading Unearthed emails: Monsanto connected to campaign to retract GMO paper
The father of a boy with a rare genetic mutation has accused a scientist of exploiting his child by proclaiming the defect a “genetic syndrome” and naming it after herself. At an impasse with scientists investigating, publicizing, and interpreting his son’s condition, the father seems willing to use any leverage he can muster to remove … Continue reading Fearing “stigmatization,” patient’s father seeks retraction of paper on rare genetic mutation
The week at Retraction Watch featured the retraction of a 35-year-old paper written by a cat, and the retraction of a study about a controversial gene editing technique. Here’s what was happening elsewhere:
Post-publication peer review isn’t just for scientists. Newspaper reporters can help correct the scientific record, too. The U.S. Centers for Disease Control and Prevention (CDC) has corrected a journal article on Legionnaire’s disease after the Pittsburgh Post-Gazette revealed what seems to be efforts by the researchers to misrepresent their data. In a series of articles … Continue reading Newspaper series prompts CDC to correct paper on Legionnaire’s disease
The author of a 2016 paper describing a potentially invaluable lab tool has retracted it, following heavy criticism from outside groups that could not reproduce the findings. The paper had already been tagged with an Expression of Concern by the journal, Nature Biotechnology, which included data from multiple groups casting doubt on the original findings. Although … Continue reading “The data have spoken:” Controversial NgAgo gene editing study retracted
The week at Retraction Watch featured an update on a Harvard lab whose PI is subject to a restraining order by one of his grad students, and the retraction of a paper that used male-only pronouns. Here’s what was happening elsewhere:
Against the authors’ objections, Nature Methods has added an expression of concern to a 2017 paper that drew fire for suggesting a common gene editing technique could cause widespread collateral damage to the genome. The latest note — the second to be added in two months — alerts readers to an alternative interpretation of the … Continue reading Controversial CRISPR paper earns second editorial note